INTRALINE® MONO 29G 38 50 6-0

INTRALINE® MONO 29G 38 50 6-0 Overview

The INTRALINE® MONO 29G 38 50 6-0 is a premium-grade PDO thread designed for aesthetic enhancements and skin rejuvenation. It uses Polydioxanone (PDO), a biocompatible material commonly utilized in sutures, to stimulate collagen production, tighten the skin, and improve elasticity.

• Fully resorbable PDO threads
• Engineered for collagen production and skin tightening
• Supports natural skin hydration and elasticity through Hyaluronic Acid stimulation

Key Features and Benefits

The INTRALINE® MONO 29G 38 50 6-0 offers unparalleled results in skin rejuvenation and elasticity improvement while being minimally invasive.

• Polydioxanone (PDO): Biocompatible and resorbable material
• Treatment longevity: Effects last up to 12–18 months
• Safety profile: Proven safe with minimal side effects
• User-friendly design: Silicone-coated needle for ease of insertion

INTRALINE® MONO 29G 38 50 6-0 Product Composition

The threads are made from Polydioxanone (PDO) and feature high tensile strength with smooth surface designs.

• Polydioxanone: Promotes Neo-collagenesis (new collagen production)
• Silicone-coated needles: Allows smooth insertion and reduced tissue trauma

INTRALINE® MONO 29G 38 50 6-0 Indications for Use

This product is ideal for patients seeking non-surgical facial rejuvenation and skin tightening.

• Primary uses: Fine line smoothing, skin tightening, and rejuvenation
• Target conditions: Sagging skin, fine wrinkles, and loss of elasticity
• Recommended applications: Face, neck, and décolletage

INTRALINE® MONO 29G 38 50 6-0 Treatment Protocol

Administered by trained professionals, this product ensures optimal results with minimal downtime.

• Insertion depth: Superficial to mid-dermis
• Techniques: Direct threading for linear applications or grid-pattern placement for wider coverage
• Recommended follow-ups: 4–6 weeks for evaluation

INTRALINE® MONO 29G 38 50 6-0 Dosage and Administration

This product is suitable for localized areas or full-face treatments depending on individual needs.

• Thread size: 29G with lengths of 38mm and 50mm
• Usage technique: Folded mono-filament designed for smooth application
• Indication-specific dosage: Determined by treatment area and severity

INTRALINE® MONO 29G 38 50 6-0 Applicable Areas

The threads are versatile and effective in treating various areas of the body.

• Face: Cheeks, nasolabial folds, and marionette lines
• Neck and décolletage: For skin tightening and wrinkle reduction
• Off-limit areas: Not recommended for highly vascular or nerve-dense regions

INTRALINE® MONO 29G 38 50 6-0 Storage and Handling

Proper handling and storage of PDO threads ensure optimal efficacy and safety.

• Storage conditions: Between 10°C–30°C, away from direct sunlight
• Shelf life: Up to 2 years if unopened and stored correctly
• Transportation requirements: Maintain product integrity during transit

INTRALINE® MONO 29G 38 50 6-0 Side Effects and Precautions

Adverse reactions are rare but can occur. Understanding these is crucial for patient safety.

• Common side effects: Mild redness, swelling, and bruising
• Rare side effects: Temporary numbness, thread extrusion, or localized infection
• Contraindications: Not for use in patients with autoimmune conditions, pregnancy, or skin infections

INTRALINE® MONO 29G 38 50 6-0 Aftercare Instructions

Adherence to aftercare recommendations maximizes results and minimizes complications.

• Immediate post-care: Avoid touching the treated area for 6 hours
• Long-term care: Use SPF 30+ sunscreen, avoid extreme temperatures, and follow a dermatologist-recommended skincare routine
• Prohibited activities: Strenuous exercise and alcohol consumption for 48 hours post-treatment

INTRALINE® MONO 29G 38 50 6-0 Drug or Product Interactions

Care should be taken when combining this product with other treatments.

• Compatibility: Works well with dermal fillers and topical treatments
• Potential interactions: Avoid concurrent use with blood-thinning medications to reduce bruising risks
• Safety guidelines: Always consult a practitioner before combining treatments

INTRALINE® MONO 29G 38 50 6-0 Clinical Evidence

Clinical studies affirm the efficacy and safety of this product in various aesthetic applications.

• Collagen stimulation: Significant increase observed within 6 weeks
• Patient satisfaction: Rated as “excellent” by over 90% of participants
• Durability: Results visible for up to 18 months

INTRALINE® MONO 29G 38 50 6-0 Regulatory and Safety Information

The product complies with strict safety standards and certifications.

• Compliance certifications: CE-approved medical device
• Batch details: Provided on packaging for traceability
• Manufacturer information: High-quality production standards upheld

INTRALINE® MONO 29G 38 50 6-0 Supplementary Information

Additional resources and complementary treatments enhance the overall patient experience.

• Complementary products: Dermal fillers for volume restoration
• Combination treatments: Works synergistically with lifting threads
• Case studies: Highlight successful applications and patient outcomes

INTRALINE® MONO 29G 38 50 6-0 Marketing and Positioning

Positioned as a premium solution for minimally invasive aesthetic enhancements.

• Ideal audience: Patients seeking natural, non-surgical rejuvenation
• Competitive advantages: Long-lasting results, safety, and ease of use
• Unique features: Advanced silicone-coated needles and superior PDO material

INTRALINE® MONO 29G 38 50 6-0 FAQ and Troubleshooting

Common inquiries and solutions ensure effective usage and patient satisfaction.

• Common questions: “How long will results last?” “Is it painful?”
• Troubleshooting issues: Contact a practitioner for persistent side effects or concerns
• Guidance for practitioners: Detailed protocols for optimal application.